(NASDAQ: IRIX) Iridex's forecast annual revenue growth rate of 10.01% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.34%.
Iridex's revenue in 2026 is $50,647,000.On average, 3 Wall Street analysts forecast IRIX's revenue for 2026 to be $991,518,104, with the lowest IRIX revenue forecast at $952,634,367, and the highest IRIX revenue forecast at $1,020,672,312. On average, 3 Wall Street analysts forecast IRIX's revenue for 2027 to be $1,054,124,015, with the lowest IRIX revenue forecast at $1,012,799,301, and the highest IRIX revenue forecast at $1,085,134,741.
In 2028, IRIX is forecast to generate $1,115,285,967 in revenue, with the lowest revenue forecast at $1,071,554,656 and the highest revenue forecast at $1,148,084,451.